Literature DB >> 33707384

Nab-paclitaxel - Third-line chemotherapy in advanced gallbladder cancer.

Amol Patel1, Bhawna Sirohi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33707384      PMCID： PMC8157898          DOI： 10.4103/ijmr.IJMR_2709_19

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  14 in total

Review 1.  Chemotherapy and targeted therapy for gall bladder cancer.

Authors:  Bhawna Sirohi; Ashish Singh; P Jagannath; Shailesh V Shrikhande
Journal:  Indian J Surg Oncol       Date:  2014-06-03

2.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

3.  Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study.

Authors:  Atul Sharma; Amit Dutt Dwary; Bidhu Kalyan Mohanti; Surya V Deo; Sujoy Pal; Vishnu Sreenivas; Vinod Raina; Nootan Kumar Shukla; Sanjay Thulkar; Pramod Garg; Surendra Pal Chaudhary
Journal:  J Clin Oncol       Date:  2010-09-20       Impact factor: 44.544

4.  Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.

Authors:  Sihem Sebbagh; Julia Roux; Chantal Dreyer; Cindy Neuzillet; Armand de Gramont; Cecilia Orbegoso; Olivia Hentic; Pascal Hammel; Aimery de Gramont; Eric Raymond; Thierry André; Benoist Chibaudel; Sandrine Faivre
Journal:  Acta Oncol       Date:  2016-06-22       Impact factor: 4.089

5.  FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients.

Authors:  Chandragouda Dodagoudar; Dinesh Chandra Doval; Anupam Mahanta; Varun Goel; Amitabh Upadhyay; Pankaj Goyal; Vineet Talwar; Sajjan Singh; Mithun Chacko John; Srikant Tiwari; Nivedita Patnaik
Journal:  Jpn J Clin Oncol       Date:  2015-11-24       Impact factor: 3.019

6.  Second-Line Palliative Chemotherapy in Advanced Gall Bladder Cancer, CAP-IRI: Safe and Effective Option.

Authors:  Anant Ramaswamy; Vikas Ostwal; Nikhil Pande; Arvind Sahu; Sunny Jandyal; Mukta Ramadwar; Nitin Shetty; Shraddha Patkar; Mahesh Goel; Sudeep Gupta
Journal:  J Gastrointest Cancer       Date:  2016-09

7.  Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial.

Authors:  Rachna T Shroff; Milind M Javle; Lianchun Xiao; Ahmed O Kaseb; Gauri R Varadhachary; Robert A Wolff; Kanwal P S Raghav; Michiko Iwasaki; Peter Masci; Ramesh K Ramanathan; Daniel H Ahn; Tanios S Bekaii-Saab; Mitesh J Borad
Journal:  JAMA Oncol       Date:  2019-06-01       Impact factor: 31.777

8.  Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer.

Authors:  Vineet Talwar; Shubhra Raina; Varun Goel; Prasanta Dash; Dinesh C Doval
Journal:  Indian J Med Res       Date:  2020-11       Impact factor: 2.375

9.  Indian Council of Medical Research consensus document for the management of gall bladder cancer.

Authors:  Hari Shankar Shukla; Bhawna Sirohi; Anu Behari; Atul Sharma; Jahar Majumdar; Manomoy Ganguly; Mallika Tewari; Sandeep Kumar; Sunil Saini; Peush Sahni; Tomcha Singh; Vinay Kumar Kapoor; V Sucharita; Tanvir Kaur; Deepak Kumar Shukla; Goura Kishor Rath
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Apr-Jun

Review 10.  Contemporary Tailored Oncology Treatment of Biliary Tract Cancers.

Authors:  Fiona Turkes; Juliet Carmichael; David Cunningham; Naureen Starling
Journal:  Gastroenterol Res Pract       Date:  2019-12-18       Impact factor: 2.260
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.